EID, Michal, Štěpán TUČEK, Markéta BEDNAŘÍKOVÁ, Dagmar BRANČÍKOVÁ and Ondřej SLABÝ. Molecularly driven therapy recommended by a molecular tumor board: Accessible option or privilege for a minority of patients? A single-center experience from the Czech Republic. In ESMO MAP. 2023.
Other formats:   BibTeX LaTeX RIS
Basic information
Original name Molecularly driven therapy recommended by a molecular tumor board: Accessible option or privilege for a minority of patients? A single-center experience from the Czech Republic
Name (in English) Molecularly driven therapy recommended by a molecular tumor board: Accessible option or privilege for a minority of patients? A single-center experience from the Czech Republic
Authors EID, Michal, Štěpán TUČEK, Markéta BEDNAŘÍKOVÁ, Dagmar BRANČÍKOVÁ and Ondřej SLABÝ.
Edition ESMO MAP, 2023.
Other information
Type of outcome Conference abstract
Confidentiality degree is not subject to a state or trade secret
Tags International impact, Reviewed
Changed by Changed by: MUDr. Michal Eid, učo 223082. Changed: 18/10/2023 11:12.
PrintDisplayed: 23/7/2024 22:18